Manufacturing News BiomeBank submits new microbial therapy for market authorisation BiomeBank, South Australian biotechnology company, has submitted its world-first biologic drug product to the Therapeutic Goods Administration for market authorisation. Read More Alexandra HaynesJuly 2, 2021, 8:43 amJuly 2, 2021 0 79